Page 246 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 246

CHAPTER 13  Radiation Oncology  225


            14.   Poirier VJ, Mayer-Stankeova S, Buchholz J, et al.: Efficacy of radia-   40.   Paganetti H: Relative biological effectiveness (RBE) values for pro-
               tion therapy for the treatment of sialocele in dogs, J Vet Intern Med   ton beam therapy. Variations as a function of biological endpoint,
               32:107–110, 2018.                                     dose, and linear energy transfer,  Phys Med Biol 59:R419–R472,
  VetBooks.ir   15.   Hubler M, Volkert M, Kaser-Hotz B, et al.: Palliative irradiation    41.   Tessonnier T, Mairani A, Brons S, et al.: Experimental dosimetric
                                                                     2014.
               of Scottish Fold osteochondrodysplasia,  Vet Radiol Ultrasound
               45:582–585, 2004.
                                                                     Phys Med Biol 62:3958–3982, 2017.
            16.   Kapatkin AS, Nordquist B, Garcia TC, et al.: Effect of single dose   comparison of (1)H, (4)He, (12)C and (16)O scanned ion beams,
               radiation therapy on weight-bearing lameness in dogs with elbow    42.   Tommasino  F: Durante M: Proton radiobiology,  Cancers (Basel)
               osteoarthritis, Vet Comp Orthop Traumatol 29:338–343, 2016.  7:353–381, 2015.
            17.   Rossi F, Cancedda S, Leone VF, et al.: Megavoltage radiotherapy    43.   Hendry JH: Survival of cells in mammalian tissues after low doses
               for the treatment of degenerative joint disease in dogs: results of a   of irradiation: a short review, Int J Radiat Biol Relat Stud Phys Chem
               preliminary experience in an italian radiotherapy centre, Front Vet   Med 53:89–94, 1988.
               Sci 5:74, 2018.                                    44.   West CM, Hendry JH: Intrinsic radiosensitivity as a predictor of
            18.   Rivers B, Walter P, McKeever J: Treatment of canine acral lick der-  patient response to radiotherapy, BJR Suppl 24:146–152, 1992.
               matitis with radiation therapy: 17 cases (1979-1991), J Am Anim    45.   Hendry JH, West CM: Apoptosis and mitotic cell death: their rela-
               Hosp Assoc 29:541–544, 1993.                          tive contributions to normal-tissue and tumour radiation response,
            19.   Owen L: Canine lick granulama treated with radiotherapy, J Sm   Int J Radiat Biol 71:709–719, 1997.
               Anim Pract 30:454–456, 1989.                       46.   Song CW, Levitt SH: Vascular changes in Walker 256 carcinoma of
            20.   Ward JF: DNA damage produced by ionizing radiation in mam-  rats following X irradiation, Radiology 100:397–407, 1971.
               malian cells: identities, mechanisms of formation, and reparability,    47.   Song CW, Kim MS, Cho LC, et al.: Radiobiological basis of SBRT
               Prog Nucleic Acid Res Mol Biol 35:95–125, 1988.       and SRS, Int J Clin Oncol 19:570–578, 2014.
            21.   Compton AH: A Quantum theory of the scattering of X-rays by    48.   Paris F, Fuks Z, Kang A, et al.: Endothelial apoptosis as the pri-
               light elements, Phys Rev 21:483–502, 1923.            mary lesion initiating intestinal radiation damage in mice, Science
            22.   Hall EJ, Giacca A: Physics and chemistry of radiation absorption.   293:293–297, 2001.
               In Hall EJ, Giacca A, editors: Radiobiology for the radiologist, ed 8,    49.   Garcia-Barros M, Paris F, Cordon-Cardo C, et al.: Tumor response
               Philadelphia, 2019, Wolters Kluwer, pp 1–10.          to radiotherapy  regulated  by endothelial  cell apoptosis,  Science
            23.   Baskar R, Dai J, Wenlong N, et al.: Biological response of cancer   300:1155–1159, 2003.
               cells to radiation treatment, Front Mol Biosci 1:24, 2014.   50.   Marin A, Martin M, Linan O, et al.: Bystander effects and radio-
            24.   Lasnitzki I: A quantitative analysis of the direct and indirect action   therapy, Rep Pract Oncol Radiother 20:12–21, 2015.
               of X radiation on malignant cells, Br J Radiol 20:240–247, 1947.   51.   Verheij  M: Clinical biomarkers and imaging for radiotherapy-
            25.   Ward JF: Radiation-induced strand breakage in DNA, Basic Life Sci   induced cell death, Cancer Metastasis Rev 27:471–480, 2008.
               5B:471–472, 1975.                                  52.   Hewitt HB, Blake E, Proter EH: The effect of lethally irradiated
            26.   Carrano  AV: Chromosome aberrations  and radiation-induced   cells on the transplantability of murine tumours,  Br J Cancer
               cell death. I. Transmission and survival parameters of aberrations,   28:123–135, 1973.
               Mutat Res 17:341–353, 1973.                        53.   Hill RP, Milas L: The proportion of stem cells in murine tumors,
            27.   Willers H, Dahm-Daphi J, Powell SN: Repair of radiation damage   Int J Radiat Oncol Biol Phys 16:513–518, 1989.
               to DNA, Br J Cancer 90:1297–1301, 2004.            54.   Jaggupilli A, Elkord E: Significance of CD44 and CD24 as can-
            28.   Santivasi  WL, Xia F: Ionizing radiation-induced DNA damage,   cer stem cell markers: an enduring ambiguity, Clin Dev Immunol
               response, and repair, Antioxid Redox Signal 21:251–259, 2014.  2012:708036, 2012.
            29.   Elkind MM, Sutton H: X-ray damage and recovery in mammalian    55.   Gerweck LE, Wakimoto H: At the crossroads of cancer stem cells,
               cells in culture, Nature 184:1293–1295, 1959.         radiation biology, and radiation oncology, Cancer Res 76:994–998,
            30.   Elkind  MM, Sutton H: Radiation response of mammalian cells   2016.
               grown in culture. 1. Repair of X-ray damage in surviving Chinese    56.   Horiot JC, Le FR, N’Guyen T, et al.: Hyperfractionated compared
               hamster cells, Radiat Res 13:556–593, 1960.           with  conventional  radiotherapy  in oropharyngeal  carcinoma:  an
            31.   Pawlik TM, Keyomarsi K: Role of cell cycle in mediating sensitivity   EORTC randomized trial, Eur J Cancer 26:779–780, 1990.
               to radiotherapy, Int J Radiat Oncol Biol Phys 59:928–942, 2004.   57.   Horiot JC, Bontemps P, Van Den Bogaert W, et al.: Accelerated
            32.   Lange SS, Takata K, Wood RD: DNA polymerases and cancer, Nat   fractionation (AF) compared to conventional fractionation (CF)
               Rev Cancer 11:96–110, 2011.                           improves loco-regional  control  in the radiotherapy  of advanced
            33.   Withers HR, Thames HD: Dose fractionation and volume effects   head and neck cancers: results of the EORTC 22851 randomized
               in normal tissues and tumors, Am J Clin Oncol 11:313–329, 1988.  trial, Radiother Oncol 44:111–121, 1997.
            34.   Terasima T, Tolmach LJ: Changes in x-ray sensitivity of HeLa cells    58.   Thames HD, Hendry JH: Response of tissues to fractionated irradi-
               during the division cycle, Nature 190:1210–1211, 1961.  ation: effect of repair. In Anonymous. Fractionation in radiotherapy,
            35.   Thomlinson  RH, Gray LH: The histological structure of some   Philadelphia, 1987, Taylor and Francis, pp 53–99.
               human lung cancers and the possible implications for radiotherapy,    59.   Vaupel P, Mayer A: Tumor oxygenation status: facts and fallacies,
               Br J Cancer 9:539–549, 1955.                          Adv Exp Med Biol 977:91–99, 2017.
            36.   Vaupel P, Mayer A: Tumor hypoxia: causative mechanisms, micro-   60.   Rockwell S, Moulder JE: Hypoxic fractions of human tumors xeno-
               regional heterogeneities, and the role of tissue-based hypoxia mark-  grafted into mice: a review, Int J Radiat Oncol Biol Phys 19:197–
               ers, Adv Exp Med Biol 923:77–86, 2016.                202, 1990.
            37.   Vaupel  P: Tumor microenvironmental physiology and its impli-   61.   Rockwell S, Moulder JE, Martin DF: Tumor-to-tumor variability
               cations for radiation oncology, Semin Radiat Oncol 14:198–206,   in the hypoxic fractions of experimental rodent tumors, Radiother
               2004.                                                 Oncol 2:57–64, 1984.
            38.   Hall EJ, Giaccia AJ: Linear Energy transfer and relative biologica    62.   Withers  HR, Taylor  JM, Maciejewski B: The hazard of acceler-
               effectiveness. In Hall EJ, Giaccia AJ, editors: Radiobiology for the   ated tumor clonogen repopulation during radiotherapy, Acta Oncol
               radiologist, ed 8, Philadelphia, 2019, Wolters Kluwer, pp 101–110.  27:131–146, 1988.
            39.   Anonymous: International Commison on Radiological Protection:    63.   Barendsen GW, Roelse H, Hermens AF, et al.: Clonogenic capac-
               Relative biological effectiveness (RBE), quality factor (Q), and radi-  ity of proliferating and nonproliferating cells of a transplantable rat
               ation weighting factor (Wr). In Anonymous. ICRP ed 60, Oxford,   rhabdomyosarcoma in relation to its radiosensitivity, J Natl Cancer
               2004, Elsevier Science.                               Inst 51:1521–1526, 1973.
   241   242   243   244   245   246   247   248   249   250   251